Brain Cancer Biobanking Australia (BCBA) is a virtual biobank hub established to provide researchers easy access to the amount, quality and type of tissue and associated data they need to accelerate both paediatric and adult translational brain cancer research.
BCBA consortium member Professor Leonie Quinn has developed the ACT’s first brain cancer biobank. The Head of Genome Science and Cancer Division at John Curtin School of Medical Research established the Canberra Brain Cancer Collaborative to enable biobanking and genomic-based brain cancer research, to benefit patients in the ACT and around the world.
“I am looking forward to building our collection and ensuring the samples are accessible to all Australian researchers as part of BCBA’s National Brain Cancer Biospecimen Register,” she said.
The new biobank will support the clinical research of Professor Quinn’s lab to better understand and identify mutations driving brain cancer and make important progress in developing new personalised brain cancer treatments.
“This will be critical for enabling targeted drug discovery research and improved outcomes for patients”.
We are delighted that BCBA’s fundraising arm, the Brain Cancer Collective (BCC), has been chosen as charity partner for the ABC’s Andrew Olle Media Lecture. The event is held annually to honour one of Australia’s most iconic broadcasters, Andrew Olle, who lost his life to brain cancer.
BCC Chair, Professor Michael Besser AM and Directors, Robyn Leonard and Sharon Bell were privileged to share the BCBA/BCC story to raise awareness and much needed funds at this prestigious media event.
16th October 2022
The 2022 Annual Meeting of the BCBA Consortium will be held in conjunction with the COGNO ASM in Brisbane on Sunday 16th October, 12.30pm – 2.30pm.
Looking forward to seeing everyone in person!